惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

O
OpenAI News
Latest news
Latest news
T
Threat Research - Cisco Blogs
Project Zero
Project Zero
V
Vulnerabilities – Threatpost
T
The Exploit Database - CXSecurity.com
Cloudbric
Cloudbric
T
Threatpost
N
News | PayPal Newsroom
I
Intezer
L
LINUX DO - 热门话题
The Hacker News
The Hacker News
H
Hacker News: Front Page
P
Proofpoint News Feed
S
Secure Thoughts
H
Help Net Security
S
Schneier on Security
TaoSecurity Blog
TaoSecurity Blog
S
Security Archives - TechRepublic
V
Visual Studio Blog
博客园 - 司徒正美
博客园 - Franky
T
Tailwind CSS Blog
aimingoo的专栏
aimingoo的专栏
AI
AI
V
V2EX - 技术
Microsoft Azure Blog
Microsoft Azure Blog
月光博客
月光博客
WordPress大学
WordPress大学
AWS News Blog
AWS News Blog
罗磊的独立博客
C
Cyber Attacks, Cyber Crime and Cyber Security
Webroot Blog
Webroot Blog
Forbes - Security
Forbes - Security
Engineering at Meta
Engineering at Meta
MyScale Blog
MyScale Blog
N
News and Events Feed by Topic
大猫的无限游戏
大猫的无限游戏
L
Lohrmann on Cybersecurity
H
Heimdal Security Blog
S
SegmentFault 最新的问题
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
D
DataBreaches.Net
Blog — PlanetScale
Blog — PlanetScale
小众软件
小众软件
Recent Commits to openclaw:main
Recent Commits to openclaw:main
B
Blog
T
Troy Hunt's Blog
Stack Overflow Blog
Stack Overflow Blog
C
CXSECURITY Database RSS Feed - CXSecurity.com

Pulse News | The HinduBusinessLine

It’s time to revise the list of essential medicines Blood donation: Humanity in every drop How PMOS pushed this student to grow her own food USFDA moots ways to reduce animal testing for cancer drugs South Africa cracks down on illegal weight-loss drugs Morning walks, home food and no devices at dinner time E-pharmacies: The missing regulatory prescription Domestic drugmakers make a play for the innovation league Gatekeeping unproven ‘harm reduction’ nicotine products Unmasking tobacco’s appeal Repurposing medicines to treat more diseases Workouts, walking, and boundaries... not burnouts Fast-tracking biopharma goals with regulatory reform Making vaccines in and for Africa Medical ethics: The perils of not speaking up Keeping infant formula free of contaminants The ‘public health crisis’ facing transgender people UK busts criminal ring supplying illegal steroids Clean hands are life-saving Cardio sessions, cricket and unwinding with music ‘Free markets’ and shackled access to medicines Inside India’s GLP-1 rush Stalling the silent spread of TB cases Meditation, play and staying curious Towards a malaria-free future Don’t hide unfavourable clinical trial results: FDA Countries take more ownership of immunisation Medical supply chain leaks: Where does the buck stop? Stand with science for universal wellbeing Wearable tech: Health monitors on the go The uncomfortable conversations over end-of-life decisions USEPA labels microplastics, pharmaceuticals as contaminants How medical myths go viral at deadly speed Gym sessions, yoga and occasional return to rollerblading Australia looks for improved ways to regulate sunscreens Slower pace of reduction in child mortality India’s silent newborn crisis Small daily habits, no quick fixes TB endgame: Yes, we can Alternatives to animal testing in drug development The pothole ‘miracle’ that wasn’t ‘Special 301’ report, in a time of strife Chile ends leprosy — a first in the Americas Hydration, protein, and AI as pocket nutritionist Making the shift to vaccinating older people Citizen-led Canadian health strategy for men and boys What women want... from health insurance Investing in women’s wellbeing beyond maternity Kidney health and planet protection Where a hospital grew from the people Aloe vera, consistent workouts, ashwagandha and magnesium More cataract surgeries needed: WHO Quality summit for the pharma industry Digital addiction: The elephant in the living room Sending medicines via the India-US trade corridor UK medical device testing hits a high BioAsia lifesciences conclave Notes of inspiration, meditation, and light kickboxing Pre-check pilot to boost local pharma manufacturing in the US Custom waiver alone cannot make medicines affordable Batting for clinical trials, but not without its ‘subjects’ WHO calls for strong cancer prevention strategies Delivering self-care over the counter Greying Kerala’s rising tide of elder care needs and health support 'Rare diseases in India aren’t rare, they’re orphaned' Indian pharma seeks R&D booster shot to stay globally competitive Quiet lakeside walks, seasonal food, and cricket Labelling info on gluten-containing grains Harmful sugary drinks are not taxed enough: WHO Budget 2026 Why research no longer needs animal cruelty The rising climate toll on body and mind Walks, vegan food and crosswords Dangers of buying illegal weight-loss drugs online Data gap hinders FDA’s safety review of cosmetics Young brigade rises in India’s pharma sector Leprosy is curable, break the stigma Fertility Inc: Inside India’s booming IVF business Fragile peace between hospitals and insurance providers Testing times loom for the ‘pharmacy of the developing world’ Medical tourism: Pitching India’s cost and care advantage Restorative eating, music for reflection, and treadmill time Mapping how everyday medicines affect gut bacteria WHO launches digital library on traditional medicine Challenges ahead in 2026 Coldrif case: When cough syrup turns poison Tackling India’s future, complex disease burden How to make health insurance truly inclusive for people with disabilities
Fragile success of HIV response
Team BL · 2026-06-15 · via Pulse News | The HinduBusinessLine

A recent UNAIDS report shows that external funding cuts, a strong pushback on human rights, and under-investment and under-prioritisation of HIV prevention and community services are threatening to reverse years of gains in the AIDS response.  

“There’s no question that this is the most serious disruption in the HIV response since the world came together to fight this disease,” said Winnie Byanyima, Executive Director of UNAIDS. “The funding cuts, combined with the reduction in civic space and the further criminalisation of marginalised populations have come together to create the biggest storm the HIV response has ever seen.” 

Dramatic cuts in aid that highly burdened, low-income countries depend on for their HIV response have had a devastating impact. Global development assistance from multiple countries fell by 23 per cent in 2025 — the sharpest drop on record — and HIV programmes have been hit hard, the agency said. HIV prevention is being dismantled at the very moment the world needs to take it to scale, especially with new, revolutionary, long-acting prevention innovations coming to market, the note said.

HIV response has been the most successful story in global health over the last 25 years, as AIDS-related deaths have been reduced by 56 per cent — from 1.3 million in 2010 to 570,000 in 2025. But this success is fragile — nearly 9 million people are not on treatment.

“We know how to end AIDS,” said Byanyima, “The question now is political: will we invest, or will we retreat? If we follow the global AIDS strategy and UN member states commit to adopting a strong political declaration to guide the response over the next five years, we can still end AIDS by 2030. However, if we fail to act, we risk reversing decades of hard-fought progress.”

Published on June 15, 2026